ABBOTT LABORATORIES — Director's Dealing 2014

Feb 25, 2014

Page 1 of 1

SEC FORM 4

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549

OMB APPROVAL

==> picture [490 x 260] intentionally omitted <==

----- Start of picture text -----

OMB Number: 3235-0287
Check this box if no longer subject STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Expires: December 31, 2014
to Section 16. Form 4 or Form 5 Estimated average burden
obligations may continue. Instruction 1(b). See Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934or Section 30(h) of the Investment Company Act of 1940 hours per response: 0.5
1. Name and Address of Reporting Person [] 2. Issuer Name and Ticker or Trading Symbol 5. Relationship of Reporting Person(s) to Issuer
White J. Scott ABBOTT LABORATORIES [ ABT ] (Check all applicable)Director 10% Owner
X Officer (give title Other (specify
3. Date of Earliest Transaction (Month/Day/Year) below) below)
(Last) (First) (Middle)
02/21/2014 Senior Vice President
100 ABBOTT PARK ROAD
4. If Amendment, Date of Original Filed (Month/Day/Year) 6. Individual or Joint/Group Filing (Check Applicable
(Street) Line)
ABBOTT X Form filed by One Reporting Person
IL 60064
PARK Form filed by More than One Reporting
Person
(City) (State) (Zip)
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction 2A. Deemed 3. 4. Securities Acquired 5. Amount of 6. 7. Nature
Date Execution Date, Transaction (A) or Disposed Of (D) Securities Ownership of Indirect
(Month/Day/Year) if any Code (Instr. (Instr. 3, 4 and 5) Beneficially Form: Beneficial
(Month/Day/Year) 8) Owned Direct (D) or Ownership
Following Indirect (I) (Instr. 4)
(A) Reported (Instr. 4)
Code V Amount or Price Transaction(s)
(D) (Instr. 3 and 4)
Common shares without par value 02/21/2014 A 15,057(1) A $ 0 91,043 D
----- End of picture text -----*

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned

• (e.g., puts, calls, warrants, options, convertible securities)

1. Title of	2.	3. Transaction	3A. Deemed	4.		5. Number	5. Number	6. Date Exercisable and	6. Date Exercisable and	7. Title and	Amount	8. Price of	9. Number	10.	11. Nature
Derivative	Conversion	Date	Execution Date,	Transaction		of		Expiration Date		of Securities		Derivative	of	Ownership	of Indirect
Security	or Exercise	(Month/Day/Year)	if any	Code	(Instr.	Derivative		(Month/Day/Year)		Underlying		Security	derivative	Form:	Beneficial
(Instr. 3)	Price of		(Month/Day/Year)	8)		Securities				Derivative Security		(Instr. 5)	Securities	Direct (D)	Ownership
	Derivative					Acquired				(Instr. 3 and 4)			Beneficially	or Indirect	(Instr. 4)
	Security					(A) or							Owned	(I) (Instr. 4)
						Disposed							Following
						of (D)							Reported
						(Instr. 3,	4						Transaction
						and 5)							(s) (Instr. 4)
											Amount
											or
											Number
								Date	Expiration		of
				Code	V	(A)	(D)	Exercisable	Date	Title	Shares
Option (right to buy) (2)	$39.12	02/21/2014		A		92,183		02/21/2015	02/20/2024	Common shares	92,183	$0	92,183	D

Explanation of Responses:

1. These shares represent performance vested restricted stock awards under the Abbott Laboratories 2009 Incentive Stock Program. The awards have a 5-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The awards include the right to have stock withheld for tax purposes.

2. Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 30,728 on 2/21/2015, 30,727 on 2/21/2016, and 30,728 on 2/21/2017.

John A. Berry, by power of 02/25/2014 attorney for J. Scott White

** Signature of Reporting Person Date

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

• If the form is filed by more than one reporting person, see Instruction 4 (b)(v).

• ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

2/25/2014